Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
06/27/2013 | WO2013096055A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
06/27/2013 | WO2013096049A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
06/27/2013 | WO2013095275A1 Novel hepatitis c virus inhibitors |
06/27/2013 | WO2013092939A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
06/27/2013 | WO2013092500A1 Substituted 4-cyan-3-phenyl-4-(pyridine-3-yl)butanoates, processes for preparation thereof and use thereof as herbicides and plant growth regulators. |
06/27/2013 | US20130165631 Bisaminoethanethiol-targeting ligand conjugates and compositions |
06/27/2013 | US20130165485 Insecticidal compounds |
06/27/2013 | US20130165451 Compounds for inflammation and immune-related uses |
06/27/2013 | US20130165440 JAK1 Inhibitors |
06/27/2013 | US20130165438 Prostaglandin d synthase inhibitory piperidine compounds |
06/27/2013 | US20130165422 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
06/27/2013 | US20130164258 Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C |
06/27/2013 | CA2857257A1 Benzyl sulfonamide derivatives as rorc modulators |
06/26/2013 | EP2606727A1 Compounds with nematicidal activity |
06/26/2013 | EP2606041A2 Compounds and methods for the treatment or prevention of flaviviridae viral infections |
06/26/2013 | EP2606036A1 New compounds |
06/26/2013 | EP2606033A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor |
06/26/2013 | EP2605652A1 Diketones and hydroxyketones as catenin signaling pathway activators |
06/26/2013 | EP2041124B1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
06/26/2013 | CN103180313A 有机电致发光装置 Organic electroluminescent device |
06/26/2013 | CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine |
06/26/2013 | CN103180296A Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
06/26/2013 | CN103180291A Alkoxyimino derivative and pest control agent |
06/26/2013 | CN103172624A Thiophene-containing organic semiconductor material and preparation method thereof and organic electroluminescent device |
06/26/2013 | CN103172623A Preparations and applications of thienyl group-containing pyrazolone derivative and its polymer film |
06/26/2013 | CN103172570A Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives |
06/26/2013 | CN102491936B Conjugated compound with yellow-green fluorescence and preparation method and use thereof |
06/26/2013 | CN101643450B Synthesis method for multi substituted 2, 3-dihydro-4(1H)-pyrimidin thionone |
06/26/2013 | CN101426780B Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
06/25/2013 | US8471019 Quinoid systems as organic semiconductors |
06/25/2013 | US8471014 Process of making gyrase and topoisomerase IV inhibitors |
06/25/2013 | US8470875 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
06/25/2013 | US8470861 Mitochondria-targeted antioxidant prodrugs and methods of use |
06/25/2013 | US8470773 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use |
06/25/2013 | CA2725425C Homocysteine synthase inhibitor |
06/25/2013 | CA2524048C Immunosuppressant compounds and compositions |
06/25/2013 | CA2285241C Substituted 3-cyano quinolines |
06/20/2013 | WO2013090929A1 Amino quinoline derivatives inhibitors of hcv |
06/20/2013 | WO2013090550A1 Novel glycoside compounds |
06/20/2013 | WO2013090454A2 Novel glp-1 receptor modulators |
06/20/2013 | WO2013090210A1 Metalloenzyme inhibitor compounds |
06/20/2013 | WO2013089087A1 Photoelectric conversion element and dye-sensitized solar cell |
06/20/2013 | WO2013088898A1 Metal complex dye, photoelectric conversion element, dye-sensitized solar cell, dye solution, and compound |
06/20/2013 | WO2013087805A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors |
06/20/2013 | WO2013087643A1 1,3,5 -triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof |
06/20/2013 | WO2013057013A3 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
06/20/2013 | US20130158258 2-aminopyrimidine modulators of the histamine h4 receptor |
06/20/2013 | US20130158076 Methylene Urea Derivatives |
06/20/2013 | US20130158044 Piperazine-substituted benzothiophenes for treatment of mental disorders |
06/20/2013 | US20130158034 Trpm8 antagonists and their use in treatments |
06/20/2013 | US20130158022 Acrylamide Compounds And Use Thereof For Inhibiting Apoptosis |
06/20/2013 | US20130158019 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
06/20/2013 | US20130158018 Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S |
06/20/2013 | US20130158017 Methods for treating or preventing cancer and neurodegenerative diseases |
06/20/2013 | US20130158015 Dual mechanism inhibitors for the treatment of disease |
06/20/2013 | US20130158003 Heteroaryl compounds and methods of use thereof |
06/20/2013 | US20130157997 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
06/20/2013 | US20130157986 Novel methylenedioxy phenolic compounds and their use to treat disease |
06/20/2013 | US20130156731 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas |
06/20/2013 | CA2857197A1 Novel glp-1 receptor modulators |
06/19/2013 | EP2604656A1 Novel azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording and inkjet recording |
06/19/2013 | EP2604597A1 Heterocyclic compound and use thereof |
06/19/2013 | EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
06/19/2013 | EP2603496A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
06/19/2013 | EP2603079A1 Positive allosteric modulators of mglur2 |
06/19/2013 | CN103159916A Difluoro-benzotriazole based co-polymer organic semiconductor material, and preparation method and application thereof |
06/19/2013 | CN103159733A Thiophene methanamide compound with NDM-1 inhibitory activity |
06/19/2013 | CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof |
06/19/2013 | CN101759814B Single or double functional group thioxanthone and photoinitiator containing same |
06/19/2013 | CN101605764B Fast dissociating dopamine 2 receptor antagonists |
06/18/2013 | USRE44304 Conjugated monomers and polymers and preparation and use thereof |
06/18/2013 | US8466301 Organic dye and dye-sensitized solar cell using the same |
06/18/2013 | CA2595218C Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
06/18/2013 | CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
06/18/2013 | CA2566212C Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives |
06/18/2013 | CA2560896C Imidazole compounds |
06/13/2013 | WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors |
06/13/2013 | WO2013085957A1 Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors |
06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
06/13/2013 | WO2013084138A1 Cyclic urea derivatives as androgen receptor antagonists |
06/13/2013 | WO2013083991A1 Novel compounds and their use in therapy |
06/13/2013 | WO2012177893A3 Trpm8 antagonists and their use in treatments |
06/13/2013 | US20130150424 Proline sulfonamide derivatives as orexin receptor antagonists |
06/13/2013 | US20130150404 Biphenyl derivatives |
06/13/2013 | US20130150374 Arylalkylamine compound and process for preparing the same |
06/13/2013 | US20130150373 Nicotinic receptor compounds |
06/13/2013 | US20130150367 Carboxamide compounds and their use as calpain inhibitors |
06/13/2013 | US20130150358 Theramutein modulators |
06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |
06/13/2013 | US20130150350 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication |
06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
06/13/2013 | US20130150341 Novel compounds |
06/13/2013 | US20130150326 Autotaxin inhibitors and uses thereof |
06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
06/12/2013 | EP2601189A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
06/12/2013 | EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
06/12/2013 | EP2475657B1 5-alkinylthien-2-ylcarboxylic acids as inhibitors of flaviviridae viruses |
06/12/2013 | CN103154018A Ligands for antibody and Fc-fusion protein purification by affinity chromatography |